BMYMP Bristol-Myers Squibb Company PFD CONV 2

USD 720.00 0.00 0
Icon

Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Stock Analysis and Price Targets

COMMON STOCK | Other | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 720.00

0.00 (0.00)%

N/A

2.00

N/A

N/A

Icon

BMYMP

Bristol-Myers Squibb Company PFD CONV 2 (USD)
COMMON STOCK | OTC
USD 720.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 720.00

Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Stock Forecast

N/A

Based on the Bristol-Myers Squibb Company PFD CONV 2 stock forecast from 0 analysts, the average analyst target price for Bristol-Myers Squibb Company PFD CONV 2 is not available over the next 12 months. Bristol-Myers Squibb Company PFD CONV 2’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bristol-Myers Squibb Company PFD CONV 2 is Neutral, which is based on 2 positive signals and 2 negative signals. At the last closing, Bristol-Myers Squibb Company PFD CONV 2’s stock price was USD 720.00. Bristol-Myers Squibb Company PFD CONV 2’s stock price has changed by +0.00% over the past week, 0% over the past month and -38.88% over the last year.

No recent analyst target price found for Bristol-Myers Squibb Company PFD CONV 2
No recent average analyst rating found for Bristol-Myers Squibb Company PFD CONV 2

Company Overview Bristol-Myers Squibb Company PFD CONV 2

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)

Loading...

Unadjusted Closing Price for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)

Loading...

Share Trading Volume for Bristol-Myers Squibb Company PFD CONV 2 Shares

Loading...

Compare Performance of Bristol-Myers Squibb Company PFD CONV 2 Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BMYMP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bristol-Myers Squibb Company PFD CONV 2 (Sector: Other )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DISPF
Disco Corporation 0.00 (0.00%) USD3,369.71B 18.60 -488.90

ETFs Containing BMYMP

Symbol Name BMYMP's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) Stock

Stock Target Advisor's fundamental analysis for Bristol-Myers Squibb Company PFD CONV 2's stock is Neutral.

Unfortunately we do not have enough data on BMYMP's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BMYMP's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BMYMP's stock to indicate if its overvalued.

The last closing price of BMYMP's stock was USD 720.00.

Unfortunately we do not currently have any market capitalization data for BMYMP's stock.

Unfortunately we do not have enough analyst data on BMYMP's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bristol-Myers Squibb Company PFD CONV 2's stock.

Sorry, we do not have any data on the number of employees for Bristol-Myers Squibb Company PFD CONV 2.

Sorry we do not have any infomation available on Bristol-Myers Squibb Company PFD CONV 2's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...